In-Person Registration for Industry Professionals | Data and Perspectives: Clinical Investigators Discuss the Current and Future Management of Diffuse Large B-Cell Lymphoma
This activity is intended for hematologists, hematology-oncology fellows, medical oncologists and other healthcare providers involved in the treatment of diffuse large B-cell lymphoma (DLBCL).